APCs	Antigen-presenting cells
CSCs	Cancer stem cells
Th	CD4+ T helper cells
CTLs	Cytotoxic CD8+ T lymphocytes
CTLA4	Cytotoxic T-lymphocyte-associated protein 4
DAMPs	Damage-associated molecular patterns
Dex	Dendritic cell-derived extracellular vesicles
DCs	Dendritic cells
ECM	Extracellular matrix
EVs	Extracellular vesicles
GMP	Good manufacturing practices
ICBs	Immune checkpoint blockers
IFN-γ	Interferon-γ
LUAD	Lung Adenocarcinoma
LC	Lung Cancer
LUSC	Lung Squamous Cell Carcinoma
MHC	Major histocompatibility complex molecules
miRNAs	MicroRNAs
M-MDSCs	Monocytic myeloid-derived suppressor cells
MDSCs	Myeloid-derived suppressor cells
NK cells	Natural Killer cells
NO	Nitric oxide
NSCLC	Non-small cell lung cancer
OS	Overall survival
PMN-MDSCs	polymorphonuclear myeloid-derived suppressor cells
PMN	Pre-metastatic niche
PD-1	Programmed cell death protein 1
PD-L1	Programmed death-ligand 1
PFS	Progression-free survival
Treg	Regulatory T cells
SCLC	Small-cell lung cancer
TIME	Tumor immune microenvironment
TME	Tumor microenvironment
TMB	Tumor mutational burden
TRAIL	Tumor necrosis factor-related apoptosis-inducing ligand
TAAs	Tumor-associated antigens
TAMs	Tumor-associated macrophages
VISTA	V-domain Ig suppressor of T-cell activation
WHO	World Health Organization